Lisanti Capital Growth LLC lifted its holdings in shares of Axonics, Inc. (NASDAQ:AXNX – Free Report) by 41.6% during the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 106,950 shares of the company’s stock after buying an additional 31,400 shares during the quarter. Axonics […]
Lisanti Capital Growth LLC lifted its stake in Axonics, Inc. (NASDAQ:AXNX – Free Report) by 41.6% in the fourth quarter, according to the company in its most recent 13F filing with the SEC. The firm owned 106,950 shares of the company’s stock after purchasing an additional 31,400 shares during the quarter. Axonics comprises 1.6% of […]
Axonics, Inc. (NASDAQ:AXNX – Get Free Report) has been given an average rating of “Hold” by the thirteen ratings firms that are presently covering the company, Marketbeat.com reports. Eight analysts have rated the stock with a hold rating and five have given a buy rating to the company. The average 1-year price target among brokers […]
Axonics (NASDAQ:AXNX – Get Free Report) released its quarterly earnings results on Tuesday. The company reported ($0.38) earnings per share for the quarter, missing analysts’ consensus estimates of ($0.06) by ($0.32), Briefing.com reports. The firm had revenue of $91.41 million for the quarter, compared to analyst estimates of $89.79 million. Axonics had a negative net […]
Axonics (NASDAQ:AXNX – Get Free Report) announced its quarterly earnings results on Tuesday. The company reported ($0.38) earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of ($0.06) by ($0.32), Briefing.com reports. Axonics had a negative net margin of 1.66% and a negative return on equity of 1.00%. The company had revenue of […]